Andrea Burnett-Hartman, PhD, MPH, BPH
Affiliate Instructor, Epidemiology
Staff Scientist, Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N. M4-B402
Seattle, WA 98109
Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.
PhD, Epidemiology, University of Washington, School of Public Health 2010
MPH, Epidemiology, University of Michigan, School of Public Health 2002
BPH, Microbiology & Ecology, Miami University (Ohio), Interdisciplinary Programs 2000
Burnett-Hartman AN, Newcomb PA, Hutter CM, Peters U, Passarelli MN, Schwartz MR, Upton MP, Zhu L, Potter JD, Makar. Association between colorectal cancer susceptibility loci and colorectal polyps varies by polyp type. Am J Epidemiol 2014;180:223-32.
Huller MAJ, Burnett-Hartman AN, Lampe JW. Gut microbes, diet, and cancer. Cancer Treat Res 2014;159:377-99.
Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu L, Upton, MP, Makar KW. Genomic Aberrations Occurring in Subsets of Serrated Colorectal Lesions but not Conventional Adenomas. Can Res 2013;73:2863-72.
Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu L, Potter JD, Newcomb PA. Differences in epidemiologic risk factors for adenomas and serrated polyps by anatomic site and lesion severity. Am J Epidemiol 2013;177:625-37.
Burnett-Hartman AN, Feng Q, Popov V, Kalidindi A, Newcomb PA. Human papillomavirus DNA is rarely detected in colorectal carcinomas and not associated with microsatellite instability: The Seattle Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2013;22:317-9.
Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev 2012;21:1792-8.
Burnett-Hartman AN, Newcomb PA, Schwartz SM, Bostick RM, Pawlita M, Waterboer T, Potter JD. No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev 2012;21:1599-601.
Burnett-Hartman AN, Newcomb PA, Phipps AI, Passarelli MN, Grady WM, Upton MP, Zhu LC, Potter JD. Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol 2012;107:1213-9.